Seipin-aKO mice show overt lipodystrophy and hepatic steatosis [44], while seipin-lKO mice neither develop hepatic steatosis even under a high-fat diet, nor have worsened metabolic disorders on top of a seipin-aKO background [51,52]. Here, BSCL2 is linked to metabolic disease.